Search research articles
Contact Us
Filters
Showing results (431-440 of 461) with videos related to
Page
of 47
Sort By:
The American Journal of Medicine
|
May 26, 2025
Higher Risk of Kidney Failure Associated With Angiotensin Receptor Blockers vs ACE Inhibitors in Patients With Heart Failure
Hans J Moore, Wen-Chih Wu, Paul A Heidenreich, et al.
Heart (British Cardiac Society)
|
May 10, 2024
Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial
Yu-Ling Yu, Justyna Siwy, De-Wei An, et al.
European Journal of Heart Failure
|
September 8, 2022
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology
Antoni Bayes-Genis, Alberto Aimo, Pardeep Jhund, et al.
European Heart Journal Open
|
August 3, 2022
Fatty acid desaturase genetic variations and dietary omega-3 fatty acid intake associate with arterial stiffness
Magnus Bäck, Constance Xhaard, Raphael Rouget, et al.
Journal of the American College of Cardiology
|
September 25, 2024
Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients With Heart Failure and Hyperkalemia
Bertram Pitt, Stefan D Anker, Lars H Lund, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
February 18, 2020
Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure)
Susan Stienen, João Pedro Ferreira, Masatake Kobayashi, et al.
European Heart Journal
|
September 4, 2012
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice
Faiez Zannad, Wendy Gattis Stough, Patrick Rossignol, et al.
Biology of Sex Differences
|
August 25, 2020
Sex differences in circulating proteins in heart failure with preserved ejection fraction
Susan Stienen, João Pedro Ferreira, Masatake Kobayashi, et al.
Lancet (London, England)
|
August 16, 2025
Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysis
Patrick Rossignol, Faiez Zannad, Ziad Massy, et al.
Circulation. Heart Failure
|
May 21, 2019
Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure
João Pedro Ferreira, Job Verdonschot, Timothy Collier, et al.
Page
of 47
Search research articles
Search
Showing results (431-440 of 461) with videos related to
Sort By:
Page
of 47
The American Journal of Medicine
|
May 26, 2025
Higher Risk of Kidney Failure Associated With Angiotensin Receptor Blockers vs ACE Inhibitors in Patients With Heart Failure
Hans J Moore, Wen-Chih Wu, Paul A Heidenreich, et al.
Heart (British Cardiac Society)
|
May 10, 2024
Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial
Yu-Ling Yu, Justyna Siwy, De-Wei An, et al.
European Journal of Heart Failure
|
September 8, 2022
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology
Antoni Bayes-Genis, Alberto Aimo, Pardeep Jhund, et al.
European Heart Journal Open
|
August 3, 2022
Fatty acid desaturase genetic variations and dietary omega-3 fatty acid intake associate with arterial stiffness
Magnus Bäck, Constance Xhaard, Raphael Rouget, et al.
Journal of the American College of Cardiology
|
September 25, 2024
Patiromer Facilitates Angiotensin Inhibitor and Mineralocorticoid Antagonist Therapies in Patients With Heart Failure and Hyperkalemia
Bertram Pitt, Stefan D Anker, Lars H Lund, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
February 18, 2020
Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure)
Susan Stienen, João Pedro Ferreira, Masatake Kobayashi, et al.
European Heart Journal
|
September 4, 2012
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice
Faiez Zannad, Wendy Gattis Stough, Patrick Rossignol, et al.
Biology of Sex Differences
|
August 25, 2020
Sex differences in circulating proteins in heart failure with preserved ejection fraction
Susan Stienen, João Pedro Ferreira, Masatake Kobayashi, et al.
Lancet (London, England)
|
August 16, 2025
Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysis
Patrick Rossignol, Faiez Zannad, Ziad Massy, et al.
Circulation. Heart Failure
|
May 21, 2019
Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure
João Pedro Ferreira, Job Verdonschot, Timothy Collier, et al.
Page
of 47